medroxyprogesterone acetate has been researched along with Hyperandrogenism in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, SS; Chung, JP; Chung, TK; Yiu, AK | 1 |
| Jeong, EG; Kim, ES; Seo, Y | 1 |
| Faure, N; Lemay, A | 1 |
| Azziz, R | 1 |
| Silfvast, A; Simberg, N; Tiitinen, A; Viinikka, L; Ylikorkala, O | 1 |
| Andersson, B; Mattsson, LA | 1 |
2 trial(s) available for medroxyprogesterone acetate and Hyperandrogenism
| Article | Year |
|---|---|
A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cross-Over Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life; Severity of Illness Index; Testosterone; Young Adult | 2014 |
High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Goserelin; Hirsutism; Humans; Hydroxyproline; Hyperandrogenism; Medroxyprogesterone Acetate; Testosterone | 1996 |
4 other study(ies) available for medroxyprogesterone acetate and Hyperandrogenism
| Article | Year |
|---|---|
Cushing's syndrome with adrenal suppression and masked hyperandrogenism by high-dose medroxyprogesterone acetate for treatment of endometrial cancer in a young woman with polycystic ovarian syndrome.
Topics: Adult; Antineoplastic Agents, Hormonal; Cushing Syndrome; Endometrial Neoplasms; Female; Humans; Hyperandrogenism; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome | 2015 |
Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
Topics: Administration, Cutaneous; Adolescent; Adult; Androstenedione; Drug Implants; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Medroxyprogesterone Acetate; Pilot Projects; Polycystic Ovary Syndrome; Progesterone; Testosterone; Uterine Hemorrhage | 1994 |
The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response.
Topics: Acanthosis Nigricans; Adolescent; Contraceptives, Oral; Drug Therapy, Combination; Female; Humans; Hyperandrogenism; Insulin Resistance; Leuprolide; Medroxyprogesterone Acetate; Spironolactone | 1994 |
The effect of transdermal estrogen replacement therapy on hyperandrogenicity and glucose homeostasis in postmenopausal women with NIDDM.
Topics: Administration, Cutaneous; Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Glucose Tolerance Test; Homeostasis; Humans; Hyperandrogenism; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners | 1999 |